Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Supine breast MRI has the potential to improve over standard prone breast magnetic resonance imaging (MRI) in terms of efficiency and image quality, image alignment with diagnostic and treatment procedures, and overall accessibility. This study aims to characterize potential technical challenges of imaging in the supine position: (i)  field inhomogeneities, (ii)  variations, (iii) respiratory-induced breast motion, and (iv) supine breast geometry.

Methods: Ten healthy subjects were scanned at 3T in both prone and supine positions to quantify and compare (i) and (ii) between both positions, and to assess (iii) in the supine position. Breast image volumes from a wider population (N = 40, healthy volunteers and patients) were analyzed to obtain breast shape metrics to characterize (iv).

Results:  field inhomogeneity increased from prone positioning (2SD: ) to supine positioning (2SD: ), and  flip angle variations (from prescribed ) were greater in the supine position (2SD ranging to ) than in the prone position (2SD ranging to ). Breast tissue displacement (median [IQR] across all analyzed locations and subjects) was similar along A-P (1.4 [0.5] mm) and R-L (1.9 [1.5] mm) directions. Breast geometry varied greatly, with the outer breast perimeter ranging from 34 to 68 cm, and maximum breast tissue thickness ranging from 2 to 9 cm.

Conclusion: Supine positioning for breast MRI may lead to greater  inhomogeneities and greater  variations when compared to prone positioning, and breast motion can be substantial. Breast geometry varies greatly among the female population, and shape metrics can inform supine-dedicated coil development.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.70029DOI Listing

Publication Analysis

Top Keywords

breast
14
supine breast
12
breast mri
12
supine position
12
supine
9
breast motion
8
shape metrics
8
prone positioning
8
positioning 2sd
8
supine positioning
8

Similar Publications

Berberine (BBR) is an isoquinoline alkaloid with a variety of biological activities, including anti-microbial and anti-tumoral activities. However, the cellular targets of BBR and the roles of BBR in the radiosensitivity of breast cancer cells are not well defined. In this study, we investigated the effects of BBR on the radiosensitivity of BT549 triple-negative breast cancer cells.

View Article and Find Full Text PDF

Mendelian Randomization Study: The Impact of Gut Microbiota on Survival in HR+ Breast Cancer Patients Under Different Treatment Regimens Through the Modulation of Immune Cell Phenotypes.

Clin Breast Cancer

August 2025

Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, School of Pharmacy, Fujian Medical University, Fuzhou, China. Electronic address:

Background: Emerging evidence suggests that the gut microbiota (GM) may influence the progression of breast cancer by modulating immune responses. Given the vast diversity of GM and immune cell phenotypes, this study aimed to utilize the most advanced and comprehensive data to explore the causal relationships among the GM, immune cell phenotypes, and survival rates in hormone receptor-positive (HR+) breast cancer patients under different treatment regimens.

Methods: We investigated the causal relationships between the GM, immune cell phenotypes, and survival rates in HR+ breast cancer patients treated with 11 distinct therapeutic strategies using Mendelian randomization.

View Article and Find Full Text PDF

Purpose: This study aimed to evaluate the performance of ChatGPT (GPT-4o) in interpreting free-text breast magnetic resonance imaging (MRI) reports by assigning BI-RADS categories and recommending appropriate clinical management steps in the absence of explicitly stated BI-RADS classifications.

Methods: In this retrospective, single-center study, a total of 352 documented full-text breast MRI reports of at least one identifiable breast lesion with descriptive imaging findings between January 2024 and June 2025 were included in the study. Incomplete reports due to technical limitations, reports describing only normal findings, and MRI examinations performed at external institutions were excluded from the study.

View Article and Find Full Text PDF